AURA BIOSCIENCES
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor-targeted pseudovirions. The company is applying nanotechnology to help fight cancer in the well-studied area of chemotherapeutics and the emerging field of RNAi. By safely eliminating cancer locally, they can treat early and transform the lives of people with a wide range of cancers that are poorly managed today. The company's goal is to treat small ocular melanomas potentially long before the disease progresses and metastasizes to the liver, where it almost always is fatal. Aura Biosciences was founded in 2007 and is headquartered in Cambridge, Massachusetts.
AURA BIOSCIENCES
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.aurabiosciences.com
Total Employee:
51+
Status:
Active
Contact:
617-812-0078
Email Addresses:
[email protected]
Total Funding:
381.36 M USD
Technology used in webpage:
Domain Not Resolving Mobile Non Scaleable Content IPv6 U.S. Server Location Common Name Invalid Apache 2.4 PHP 7 COVID-19 Ubuntu Akamai Hosted
Similar Organizations
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Avidity Biosciences
Avidity Biosciences is a biotechnology company that develops oligonucleotide-based therapies for its patients.
Exscientia
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
GRO Biosciences
GRO Biosciences is a biotechnology company that expands the amino acid alphabet to overcome the limitations of protein therapeutics.
MediWound
MediWound is a biotechnology specialty company focused on developing, manufacturing and commercializing innovative wound care products.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Telix Pharmaceuticals
Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing drug discovery by enabling dry lab predictions with wet lab validation.
Zealand Pharma
Zealand Pharma is a biotechnology company that offers scientific expertise in turning peptides into medicines.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Ysios Capital
Ysios Capital investment in Post-IPO Equity - Aura Biosciences
Ysios Capital
Ysios Capital investment in Venture Round - Aura Biosciences
Advent Life Sciences
Advent Life Sciences investment in Venture Round - Aura Biosciences
Velosity Capital
Velosity Capital investment in Venture Round - Aura Biosciences
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Venture Round - Aura Biosciences
Arix Bioscience
Arix Bioscience investment in Venture Round - Aura Biosciences
Chiesi Ventures
Chiesi Ventures investment in Venture Round - Aura Biosciences
Adage Capital Management
Adage Capital Management investment in Venture Round - Aura Biosciences
Medicxi
Medicxi investment in Venture Round - Aura Biosciences
Rock Springs Capital
Rock Springs Capital investment in Venture Round - Aura Biosciences
Official Site Inspections
http://www.aurabiosciences.com Semrush global rank: 3.72 M Semrush visits lastest month: 3.26 K
- Host name: dp-aba716029d.dreamhostps.com
- IP address: 208.113.243.238
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Aura Biosciences"
Aura Biosciences - Crunchbase Company Profile
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor-targeted pseudovirions. The company is applying nanotechnology to help fight cancer in the well-studied area of …See details»
Events and Presentations - Aura Biosciences
Oct 17, 2024 The Investor Relations website contains information about Aura Biosciences's business for stockholders, potential investors, and financial analysts.See details»
Aura Biosciences, Inc. (AURA)
See the company profile for Aura Biosciences, Inc. (AURA) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Management - Aura Biosciences
Senior Vice President, Therapeutic Area Head Urologic Oncology Anthony Daniels, MD. Vice President, Therapeutic Area Head Ocular OncologySee details»
Overview - Aura Biosciences
Our Mission. At Aura, our mission is to develop a new class of oncology targeted therapies that deliver meaningful therapeutic benefit to a range of cancer indications with high unmet need in which we believe we can establish a new …See details»
Aura Biosciences, Inc. (AURA) Company Profile & Overview - Stock …
Oct 29, 2021 Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company’s proprietary platform enables …See details»
Aura Biosciences - LinkedIn
Aura Biosciences is a clinical-stage biotechnology company developing virus-like drug conjugates (VDC), a novel class of therapies, for the treatment of multiple oncology indications.See details»
Committee Composition - Aura Biosciences
The Investor Relations website contains information about Aura Biosciences's business for stockholders, potential investors, and financial analysts.See details»
Main Menu - ir.aurabiosciences.com
Dec 11, 2017 Before that, he established a new center of excellence in ophthalmology at Quintiles Transnational (now IQVIA), the world’s largest contract research organization. Dr. …See details»
Aura Biosciences Reports Fourth Quarter and Full Year 2023 …
BOSTON, March 27, 2024--Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors to …See details»
Aura Biosciences, Inc. (AURA) - Yahoo Finance
Find the latest Aura Biosciences, Inc. (AURA) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Aura Biosciences Expands Executive Leadership Team and Board of ...
Sep 29, 2021 Chris Primiano, J.D., Appointed as Chief Business Officer. Antony Mattessich Appointed to the Board of Directors . CAMBRIDGE, MA – September 29, 2021 – Aura …See details»
Aura Biosciences Expands Executive Leadership Team and Board of ...
Sep 29, 2021 For more information, visit www.aurabiosciences.com or follow us on Twitter. Contacts. Investor and Media Contact: Matthew DeYoung Argot Partners 914-330-6516 | …See details»
Aura Biosciences Reports Fourth Quarter and Full Year 2022 …
Mar 15, 2023 Research and development expenses increased to $13.2 million and $42.2 million for the three months and full year ended December 31, 2022, respectively, from $8.0 million …See details»
Aura Biosciences Appoints David Johnson to Its Board of Directors
CAMBRIDGE, MA –January 5th, 2021– Aura Biosciences, a clinical-stage oncology company developing a novel class of drug conjugate therapies for multiple oncology indications, today …See details»
Aura Biosciences, Inc. (AURA) Stock Price, Quote & News - Stock …
Website https://www.aurabiosciences.com. Full Company Profile. Financial Performance. Financial Statements. Analyst Forecast. According to 4 analysts, the average rating for AURA …See details»
Aura Biosciences Reports First Quarter 2022 Financial Results and ...
Mar 31, 2022 For more information, visit aurabiosciences.com, or follow us on Twitter and LinkedIn. Forward Looking Statement. This press release contains forward-looking statements …See details»
Pipeline - Aura Biosciences
Aura is developing a pipeline of virus-like drug conjugate, or VDC, therapeutic candidates for high unmet need cancers that are either have no approved drugs available or are poorly managed …See details»
Bladder Cancer - Aura Biosciences
Bladder cancer is the most common malignancy involving the urinary system and approximately 84,000 Americans will be diagnosed with bladder cancer in 2021.See details»